Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

Nature Biotechnology

Volumn 33, Issue 7, 2015, Pages 685-686

  Price, W Nicholson ^a   Minssen, Timo ^b  

^a Franklin Pierce Law Center   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG EFFICACY; DRUG MARKETING; DRUG SAFETY; DRUG USE; INFORMATION PROCESSING; LETTER; PATENT; PRIORITY JOURNAL; PROFESSIONAL SECRECY; REIMBURSEMENT; CLINICAL TRIAL (TOPIC); DRUG DEVELOPMENT; DRUG INDUSTRY; ECONOMICS; EUROPE; HUMAN; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE;

CLINICAL TRIALS AS TOPIC; DISCLOSURE; DRUG DISCOVERY; DRUG INDUSTRY; EUROPE; HUMANS; PATENTS AS TOPIC;

EID: 84953375283     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3243     Document Type: Letter

References (13)

1. European Medicines Agency. Publication of clinical reports. http://www.ema.europa.eu/ema/index. jsp?curl=pages/news-and-events/news/2014/10/news-detail-002181.jsp&mid=WC0b01ac058004d5c1 (2 October 2014).
2. The Council of the European Union. Council adopts new rules on clinical trials. http://www.consilium.europa.eu/uedocs/cms-data/docs/pressdata/en/lsa/142181.pdf (14 April 2014).
3. US Food and Drug Administration. Fed. Reg. 78, 33421-33423 (2013).
4. Mello, M.M. et al. N. Engl. J. Med. 369, 1651-1658 (2013).
5. Roin, B.N. Social Science Research Network http://dx.doi.org/10.2139/ssrn.2337821 (October 10, 2013)
6. Doshi, P. Br. Med. J. 347, f6754 (2013).
7. DiMasi, J.A., Reichert, J.M., Feldman, L. , Malins, A. Clin. Pharmacol. Ther. 94, 329-335 (2013).
8. MEHL/Biophile Int'l Corp. v. Milgraum, 192 F.3d 1362 (1999).
9. T128/82 (Pyrrolidin-Derivate) Case T 128/82-Hoffman-La Roche/Pyrrolidine-derivatives O.J. EPO 1984, 164 (Jan. 12, 1984)
10. G2/08 (Dosage regime/Abbott Respiratory) Case G 2/08-Dosage regime/Abbott Respiratory 2010 O.J. EPO 456 (Feb. 19, 2010)
11. Torjesen, I. Br. Med. J. 348, g3432 (2014).
12. EU Commission, COM/2013/0813 final-2013/0402 (COD), Proposal for a Directive of the European Parliament and of the Council on the protection of undisclosed know-how and business information (trade secrets) against their unlawful acquisition, use and disclosure. http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52013PC0813 (Nov. 28, 2013)
13. European Federation of Pharmaceutical Industries and Associations. EFPIA welcomes the Commission's Proposal on the protection of undisclosed know-how and business information ("Trade Secrets"). http://www.efpia.eu/mediaroom/129/44/EFPIA-welcomesthe-Commission-39-s-Proposal-on-the-protection-ofundisclosed-know-how-and-business-information-quot-Trade-Secrets-quot (28 November 2013).